Back

Examining the link: type 2 diabetes and cardiovascular disease

1 September 2019 (13:05 - 13:20)
Organised by:
Congress Presentation Part of: Multi-dimensional glucagon-like peptide-1 receptor agonists — Positioning their role in treatment of type 2 diabetes and cardiovascular disease Diabetes and the Heart ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Lars Ryden

Karolinska Institute, Stockholm (Sweden)

4 More presentations in this session

Presentation thumbnail
Chair’s Welcome
Professor L. Ryden (Stockholm, SE)
Video
Presentation thumbnail
Gazing into the future opportunities of glucagon-like peptide-1 receptor agonists in cardiovascular disease
Professor S. Verma (Toronto, CA)
Video
Presentation thumbnail
“Belling the Cat” - Practical guide for cardiologists on Incorporating GLP-1RAs into comprehensive cardiovascular risk reduction
Doctor M. Kosiborod (Kansas City, US)
Video
Presentation thumbnail
Connecting with the speakers - Questions and answers
Professor L. Ryden (Stockholm, SE) Professor S. Verma (Toronto, CA) Doctor M. Kosiborod (Kansas City, US)
Video

Access the full session

Session thumbnail
Multi-dimensional glucagon-like peptide-1 receptor agonists — Positioning their role in treatment of type 2 diabetes and cardiovascular disease

The Event

Event poster

ESC Congress 2019

1 September 2019 13:05 CET
You may be interested in
thumbnail
Webinar
EAPC Webinar: Type 2 Diabetes and cardiovascular risk
12 March 2019
thumbnail
Congress Presentation
Association of kidney and cardiovascular outcomes in patients with type 2 diabetes mellitus: insights from the EMPA-REG OUTCOME trial
29 June 2021
thumbnail
Congress Presentation
Incidence of depression in type 2 diabetes patients with and without cardiovascular disease
26 August 2023
thumbnail
Congress Presentation
Prediabetes and risk of cardiovascular disease among 1.3 million patients from an integrated health care system
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources